THE REFERENCES FROM THE BOOK "SURVIVAL 'TERMINAL' CANCER" BY BEN
WILLIAMS
Chapter 1 - Diagnosis: Glioblastoma multiforme "The
Terminator"
Chapter 2 - Searching for Treatment
Glioblastoma Newsletter, 24 Sept. 2002, Vol. 1, No. 5
Chapter 3 - Improving My Odds for Survival
Chapter 4 - Salvaging a Life
Chapter 5 - Toward a Rational Treatment Strategy
Chapter 6 - Shared Experiences
Glioblastoma Newsletter, 30 Oct. 2002, Vol.1, No.12
Chapter 7 - Conventions of
the Medical System and Their Ramifications
Chapter 8 -
Arbitrary Policies Exclude Promising Treatment
Chapter 9 -
Ethical Implications of the Clinical Trial System
Chapter 10 -
Phase-III Trials: Gold Standard or Fool's Gold?
Chapter 11 - Bastille Day
for Cancer Patient
Glioblastoma Newsletter, 2 Nov. 2002, Vol.1, No.13
|
| Chapter 12 - Alternative
Medicine |
1, 2, 3, 4, 5, 6 N.A.
|
| 7 |
Chlebowski
RT, Lillington L, Nystrom JS, Sayre J
Late
mortality and levamisole adjuvant therapy in colorectal cancer
Br J
Cancer 1994 Jun;69(6):1094-7 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8198976&dopt=Abstract
|
8, 9, 10 N.A.
|
| 11 |
Filov VA, Gershanovich ML, Danova LA, Ivin BA
Experience
of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer
patients
Invest New
Drugs 1995;13(1):89-97 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7499115&dopt=Abstract
|
| 12 |
N.A.
|
| 13 |
Chlebowski
RT, Bulcavage L, Grosvenor M, Oktay E, Block JB, Chlebowski JS,
Ali I, Elashoff R
Hydrazine
sulfate influence on nutritional status and survival in non-small-cell lung
cancer
J
Clin Oncol 1990 Jan;8(1):9-15 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1688616&dopt=Abstract
|
| 14 |
Loprinzi
CL, Kuross SA, O'Fallon JR, Gesme DH Jr, Gerstner JB, Rospond RM, Cobau CD,
Goldberg RM.
Randomized
placebo-controlled evaluation of hydrazine sulfate in patients with advanced
colorectal cancer
J
Clin Oncol 1994 Jun;12(6):1121-5 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8201373&dopt=Abstract
|
| 15 |
Kosty
MP, Fleishman SB, Herndon JE 2nd, Coughlin K, Kornblith AB, Scalzo A, Morris
JC, Mortimer J, Green MR
Cisplatin,
vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a
randomized placebo-controlled, double-blind phase III study of the Cancer and
Leukemia Group B
J Clin Oncol 1994 Jun;12(6):1113-20 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8201372&dopt=Abstract
|
| 16 |
Loprinzi
CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW,
Jett JR, Ghosh C, Pfeifle DM, et al
Placebo-controlled
trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung
cancer
J
Clin Oncol 1994 Jun;12(6):1126-9 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8201374&dopt=Abstract
|
| 17 |
Kaegi
E
Unconventional
therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the
Canadian Breast Cancer Research Initiative
CMAJ
1998 May 5;158(9):1157-9 (Review Article, Reference | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9597967&dopt=Abstract
Free full text article (PDF format): http://www.cmaj.ca/cgi/reprint/158/9/1157?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=
Kaegi&searchid=1035268682207_5&stored_search=&FIRSTINDEX=0&journalcode=cmaj
|
| 18 |
N.A.
|
| 19 |
Kuttan G, Menon LG, Antony S, Kuttan
R
Anticarcinogenic
and antimetastatic activity of Iscador
Anticancer
Drugs 1997 Apr;8 Suppl 1:S15-6 (Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9179361&dopt=Abstract
|
| 20 |
Antony
S, Kuttan R, Kuttan G
Effect
of viscum album in the inhibition of lung metastasis in mice induced by B16F10
melanoma cells
J Exp
Clin Cancer Res 1997 Jun;16(2):159-62 (Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9261741&dopt=Abstract
|
| 21 |
Kuttan G, Kuttan R
Reduction
of leukopenia in mice by "viscum album" administration during
radiation and chemotherapy
Tumori 1993 Feb
28;79(1):74-6 (Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8497925&dopt=Abstract
|
| 22 |
Lenartz
D, Stoffel B, Menzel J, Beuth J.
Immunoprotective
activity of the galactoside-specific lectin from mistletoe after tumor
destructive therapy in glioma patients
Anticancer
Res 1996 Nov-Dec;16(6B):3799-802 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9042260&dopt=Abstract
|
| 23 |
Lenartz
D, Dott U, Menzel J, Schierholz JM, Beuth J
Survival
of glioma patients after complementary treatment with galactoside-specific
lectin from mistletoe
Anticancer
Res 2000 May-Jun;20(3B):2073-6 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10928154&dopt=Abstract
|
| 24 |
Jagiello-Wojtowicz
E, Kleinrok Z, Urbanska EM
Ukrain
(NSC-631570) in experimental and clinical studies: a review
Drugs Exp Clin Res 1998;24(5-6):213-9 (Review
Article, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10190077&dopt=Abstract
|
| 25 |
Not Found
|
| 26 |
Susak
YM, Zemskov VS, Yaremchuk OY, Kravchenco OB, Yatsyk IM, Korsh OB
Comparison
of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer
Drugs Exp Clin Res 1996;22(3-5):115-22 (Clinical
Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8899313&dopt=Abstract
|
| 27 |
Zemskov
VS, Procopchuk OL, Susak YM, Zemskov SV, Hodysh YY, Zemskova MV
Ukrain
(NSC-631570) in the treatment of pancreas cancer
Drugs Exp Clin Res 2000;26(5-6):179-90 (Clinical
Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11345025&dopt=Abstract
|
| 28 |
Jaeckle
KA, Mittelman A, Hill FH
Phase
II trial of Serratia marcescens extract in recurrent malignant astrocytoma
J
Clin Oncol 1990 Aug;8(8):1408-18 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2199624&dopt=Abstract
|
| 29 |
Csatary
LK, Eckhardt S, Bukosza I, Czegledi F, Fenyvesi C, Gergely P, Bodey B,
Csatary CM
Attenuated
veterinary virus vaccine for the treatment of cancer
Cancer
Detect Prev 1993;17(6):619-27 (Clinical Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8275514&dopt=Abstract
|
| 30 |
Batliwalla
FM, Bateman BA, Serrano D, Murray D, Macphail S, Maino VC, Ansel JC,
Gregersen PK, Armstrong CA
A
15-year follow-up of AJCC stage III malignant melanoma patients treated
postsurgically with Newcastle disease virus (NDV) oncolysate and determination
of alterations in the CD8 T cell repertoire
Mol
Med 1998 Dec;4(12):783-94 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9990864&dopt=Abstract
|
| 31 |
de
la Taille A, Buttyan R, Hayek O, Bagiella E, Shabsigh A, Burchardt M,
Burchardt T, Chopin DK, Katz AE
Herbal
therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients
with prostate cancer
J
Urol 2000 Oct;164(4):1229-34 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10992371&dopt=Abstract
|
| 32 |
N.A.
|
| 33 |
Not Found
|
| 34 |
Buckner
JC, Malkin MG, Reed E, Cascino TL, Reid
JM, Ames MM, Tong WP, Lim S, Figg WD
Phase II study of antineoplastons A10
(NSC 648539)
and AS2-1 (NSC 620261) in patients with recurrent glioma
Mayo
Clin Proc 1999 Feb;74(2):137-45 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10069350
|
| 35 |
Not Found
|
| 36 |
N.A.
|
|